Rhinosinusitis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform

Richard M Rosenfeld - One of the best experts on this subject based on the ideXlab platform.

  • clinical practice guideline update adult sinusitis
    Otolaryngology-Head and Neck Surgery, 2015
    Co-Authors: Richard M Rosenfeld, Maggie A Kramper, Jay F Piccirillo, Sujana S Chandrasekhar, Itzhak Brook, Kaparaboyna Ashok Kumar, Richard R Orlandi, James N Palmer, Zara M Patel, Anju T Peters
    Abstract:

    ObjectiveThis update of a 2007 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to manage adult Rhinosinusitis, defined as symptomatic inflammation of the paranasal sinuses and nasal cavity. Changes from the prior guideline include a consumer added to the update group, evidence from 42 new systematic reviews, enhanced information on patient education and counseling, a new algorithm to clarify action statement relationships, expanded opportunities for watchful waiting (without antibiotic therapy) as initial therapy of acute bacterial Rhinosinusitis (ABRS), and 3 new recommendations for managing chronic Rhinosinusitis (CRS).PurposeThe purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing adult Rhinosinusitis and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy for adu...

  • extracts from the cochrane library nasal saline irrigations for the symptoms of chronic Rhinosinusitis
    Otolaryngology-Head and Neck Surgery, 2007
    Co-Authors: Martin J Burton, Lee D Eisenberg, Richard M Rosenfeld
    Abstract:

    The “Cochrane Corner” is a quarterly section in the journal that highlights systematic reviews relevant to otolaryngology–head and neck surgery, with invited commentary to highlight implications for clinical decision-making. This installment features a Cochrane Review entitled “Nasal saline irrigations for the symptoms of chronic Rhinosinusitis,” which shows that saline irrigations are well-tolerated and could be included as a treatment adjunct for the symptoms of chronic Rhinosinusitis.

  • clinical practice guideline on adult sinusitis
    Otolaryngology-Head and Neck Surgery, 2007
    Co-Authors: Richard M Rosenfeld
    Abstract:

    This executive summary will alert clinicians to key evidence-based statements in a multidisciplinary, clinical practice guideline on adult sinusitis developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation. Included in the guideline are 17 boldfaced action statements: 3 on viral Rhinosinusitis, 7 on acute bacterial Rhinosinusitis, and 7 on chronic Rhinosinusitis and recurrent acute Rhinosinusitis. Evidence profiles that accompany each statement are summarized to show why it was made and how it can be implemented. Guideline statements regarding acute Rhinosinusitis focus on diagnosing presumed bacterial illness and using antibiotics appropriately. Guideline statements regarding chronic Rhinosinusitis or recurrent acute Rhinosinusitis focus on appropriate use of diagnostic tests. Surgical therapy is not discussed.

Jay F Piccirillo - One of the best experts on this subject based on the ideXlab platform.

  • clinical practice guideline update adult sinusitis
    Otolaryngology-Head and Neck Surgery, 2015
    Co-Authors: Richard M Rosenfeld, Maggie A Kramper, Jay F Piccirillo, Sujana S Chandrasekhar, Itzhak Brook, Kaparaboyna Ashok Kumar, Richard R Orlandi, James N Palmer, Zara M Patel, Anju T Peters
    Abstract:

    ObjectiveThis update of a 2007 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to manage adult Rhinosinusitis, defined as symptomatic inflammation of the paranasal sinuses and nasal cavity. Changes from the prior guideline include a consumer added to the update group, evidence from 42 new systematic reviews, enhanced information on patient education and counseling, a new algorithm to clarify action statement relationships, expanded opportunities for watchful waiting (without antibiotic therapy) as initial therapy of acute bacterial Rhinosinusitis (ABRS), and 3 new recommendations for managing chronic Rhinosinusitis (CRS).PurposeThe purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing adult Rhinosinusitis and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy for adu...

  • the effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic Rhinosinusitis
    Archives of Otolaryngology-head & Neck Surgery, 2009
    Co-Authors: Neil Sachanandani, Maggie A Kramper, S.e. Thawley, Jay F Piccirillo, Anna Vlahiotis
    Abstract:

    Objectives To evaluate whether nasal administration of budesonide in adults with chronic Rhinosinusitis for 30 days suppresses adrenal function and to assess its clinical efficacy. Design An open-label prospective study. Setting Academic medical center. Patients We assessed adrenal function in 9 patients using the cosyntropin test before and after budesonide therapy. Intervention Budesonide respule therapy. Main Outcome Measure Scores from the Sino-Nasal Outcome Test–20 (SNOT-20), a tool for assessing Rhinosinusitis health and quality of life, were used to assess efficacy of budesonide treatment. Results All of our patients showed adequate adrenal response to cosyntropin stimulation before and after the budesonide trial. The mean difference in SNOT-20 scores was −1 (95% confidence interval, −1.77 to −0.23; P  = .02), indicating clinically significant improvement after therapy. Conclusion Our findings suggest that using budesonide nasal wash may be clinically effective in decreasing the symptoms of chronic Rhinosinusitis and does so without suppression of the hypothalamic-pituitary-adrenal axis in patients with chronic Rhinosinusitis.

  • psychometric and clinimetric validity of the 20 item sino nasal outcome test snot 20
    Otolaryngology-Head and Neck Surgery, 2002
    Co-Authors: Jay F Piccirillo, Michael G Merritt, Michele L Richards
    Abstract:

    A valid measure of Rhinosinusitis health status and quality of life is required for the complete assessment of treatment effectiveness. The purpose of this study was to analyze the psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20), a disease-specific, health-related quality-of-life measure for Rhinosinusitis. The SNOT-20 is a modification of the 31-Item Rhinosinusitis Outcome Measure, and it contains 20 nose, sinus, and general items. To complete the instrument, patients indicate how much they are affected in each area and identify the 5 most important items. The SNOT-20 was completed by 102, 72, and 46 patients at the initial visit and at 6 months and 1 year after treatment commencement, respectively. Cronbach's alpha was 0.9; test-retest scores were highly correlated (r = 0.9). Patients who were more affected had greater SNOT-20 scores (P < 0.002), and patients who had improved had greater change scores (P < 0.04). Items identified as important had greater scores (P < 0.0001) and showed greater change scores (P < 0.0002). The SNOT-20 is a valid outcome measure for patients with Rhinosinusitis; it describes the health burden and is sensitive to clinical change.

Donald A Leopold - One of the best experts on this subject based on the ideXlab platform.

  • treatment of acute and chronic Rhinosinusitis in the united states 1999 2002
    Archives of Otolaryngology-head & Neck Surgery, 2007
    Co-Authors: Hadley J Sharp, David Denman, Susan E Puumala, Donald A Leopold
    Abstract:

    Objective To generalize the prescribing trends of a statistically defined sample of patient visits because of acute or chronic Rhinosinusitis in the United States, using reported diagnostic codes from the International Classification of Diseases, Ninth Revision, Clinical Modification . Design Four-year prospective study. Setting Public use data from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey collected by the National Center for Health Statistics. Results The most frequently recommended medications for treatment of both acute and chronic Rhinosinusitis are antibiotic agents, followed by antihistamines; nasal decongestants; corticosteroids; and antitussive, expectorant, and mucolytic agents, respectively. In addition, corticosteroids are used for the treatment of chronic Rhinosinusitis. Conclusions The use of prescription antibiotics far outweighs the predicted incidence of bacterial causes of acute and chronic Rhinosinusitis. Frequency of antibiotic class used was not congruent with reported antimicrobial efficacy of the respective classes. Despite contradictory efficacies reported in the literature, inhaled corticosteroids were frequently used to treat acute Rhinosinusitis. Antibiotics and inhaled nasal corticosteroids are being used more often than their published efficacies would encourage.

Timothy L. Smith - One of the best experts on this subject based on the ideXlab platform.

Itzhak Brook - One of the best experts on this subject based on the ideXlab platform.

  • clinical practice guideline update adult sinusitis
    Otolaryngology-Head and Neck Surgery, 2015
    Co-Authors: Richard M Rosenfeld, Maggie A Kramper, Jay F Piccirillo, Sujana S Chandrasekhar, Itzhak Brook, Kaparaboyna Ashok Kumar, Richard R Orlandi, James N Palmer, Zara M Patel, Anju T Peters
    Abstract:

    ObjectiveThis update of a 2007 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to manage adult Rhinosinusitis, defined as symptomatic inflammation of the paranasal sinuses and nasal cavity. Changes from the prior guideline include a consumer added to the update group, evidence from 42 new systematic reviews, enhanced information on patient education and counseling, a new algorithm to clarify action statement relationships, expanded opportunities for watchful waiting (without antibiotic therapy) as initial therapy of acute bacterial Rhinosinusitis (ABRS), and 3 new recommendations for managing chronic Rhinosinusitis (CRS).PurposeThe purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing adult Rhinosinusitis and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy for adu...

  • acute sinusitis in children
    Pediatric Clinics of North America, 2013
    Co-Authors: Itzhak Brook
    Abstract:

    Acute Rhinosinusitis is a common illness in children. Viral upper respiratory tract infection is the most common presentation of Rhinosinusitis. Most children resolve the infection spontaneously and only a small proportion develops a secondary bacterial infection. The proper choice of antibiotic therapy depends on the likely infecting pathogens, bacterial antibiotic resistance, and pharmacologic profiles of antibiotics. Amoxicillin-clavulanate is currently recommended as the empiric treatment in those requiring antimicrobial therapy. Isolation of the causative agents should be considered in those who failed the initial treatment. In addition to antibiotics, adjuvant therapies and surgery may be used in the management of acute bacterial Rhinosinusitis.